findmyKOL
Clinical trialNCT00003039CompletedPhase 2Interventional

Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma

SponsorNational Cancer Institute (NCI)Enrollment40Lymphoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Clinical Sciences Building

    Chicago, Illinois, United States

  • Louis A. Weiss Memorial Hospital

    Chicago, Illinois, United States

  • University of Chicago Cancer Research Center

    Chicago, Illinois, United States

  • Cancer Care Specialists of Central Illinois, S.C.

    Decatur, Illinois, United States

  • Evanston Northwestern Health Care

    Evanston, Illinois, United States

  • Lutheran General Hospital

    Park Ridge, Illinois, United States

  • Oncology/hematology Associates of Central Illinois, P.C.

    Peoria, Illinois, United States

  • Central Illinois Hematology Oncology Center

    Springfield, Illinois, United States

  • Fort Wayne Medical Oncology and Hematology, Inc.

    Fort Wayne, Indiana, United States

  • Michiana Hematology/oncology P.C.

    South Bend, Indiana, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 1997
Primary completion
30 Apr 2000
Completion
Last update posted
5 Feb 2013
Registered enrollment
40
Registry id
NCT00003039

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.